Angiogenesis and End-MT may play important roles in cardiac hypertrophy and fibrosis, both of which are regulated by activated MR-induced upregulation of the VEGFA/VEGFR2 signaling pathway. This evidence concerns the gene VEGFA and cardiac hypertrophy.